Seroogy J - Search Results

1

Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety.

Cohen F, Aggen JB, Andrews LD, Assar Z, Boggs J, Choi T, Dozzo P, Easterday AN, Haglund CM, Hildebrandt DJ, Holt MC, Joly K, Jubb A, Kamal Z, Kane TR, Konradi AW, Krause KM, Linsell MS, Machajewski TD, Miroshnikova O, Moser HE, Nieto V, Phan T, Plato C, Serio AW, Seroogy J, Shakhmin A, Stein AJ, Sun AD, Sviridov S, Wang Z, Wlasichuk K, Yang W, Zhou X, Zhu H, Cirz RT. Cohen F, et al. Among authors: seroogy j. ChemMedChem. 2019 Aug 20;14(16):1560-1572. doi: 10.1002/cmdc.201900287. Epub 2019 Aug 5. ChemMedChem. 2019. PMID: 31283109

2

A Phase 1 Study of Intravenous Plazomicin in Healthy Adults to Assess Potential Effects on the QT/QTc Interval, Safety, and Pharmacokinetics.

Gall J, Choi T, Riddle V, Van Wart S, Gibbons JA, Seroogy J. Gall J, et al. Among authors: seroogy j. Clin Pharmacol Drug Dev. 2019 Nov;8(8):1032-1041. doi: 10.1002/cpdd.653. Epub 2019 Jan 16. Clin Pharmacol Drug Dev. 2019. PMID: 30650259 Clinical Trial.

3

Pharmacokinetics, serum inhibitory and bactericidal activity, and safety of telavancin in healthy subjects.

Shaw JP, Seroogy J, Kaniga K, Higgins DL, Kitt M, Barriere S. Shaw JP, et al. Among authors: seroogy j. Antimicrob Agents Chemother. 2005 Jan;49(1):195-201. doi: 10.1128/AAC.49.1.195-201.2005. Antimicrob Agents Chemother. 2005. PMID: 15616296 Free PMC article. Clinical Trial.

4

A Phase 1 Study To Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function.

Komirenko AS, Riddle V, Gibbons JA, Van Wart S, Seroogy JD. Komirenko AS, et al. Among authors: seroogy jd. Antimicrob Agents Chemother. 2018 Nov 26;62(12):e01128-18. doi: 10.1128/AAC.01128-18. Print 2018 Dec. Antimicrob Agents Chemother. 2018. PMID: 30275092 Free PMC article. Clinical Trial.

5

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies.

Trang M, Seroogy JD, Van Wart SA, Bhavnani SM, Kim A, Gibbons JA, Ambrose PG, Rubino CM. Trang M, et al. Among authors: seroogy jd. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02329-18. doi: 10.1128/AAC.02329-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30670433 Free PMC article.

6

A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant Enterobacterales.

Asempa TE, Kuti JL, Seroogy JD, Komirenko AS, Nicolau DP. Asempa TE, et al. Among authors: seroogy jd. Clin Ther. 2019 Aug;41(8):1453-1462. doi: 10.1016/j.clinthera.2019.04.038. Epub 2019 Jun 24. Clin Ther. 2019. PMID: 31248681 Clinical Trial.

7

Application of the Hartford Hospital Nomogram for Plazomicin Dosing Interval Selection in Patients with Complicated Urinary Tract Infection.

Asempa TE, Kuti JL, Seroogy JD, Komirenko AS, Nicolau DP. Asempa TE, et al. Among authors: seroogy jd. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00148-19. doi: 10.1128/AAC.00148-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31358580 Free PMC article. Clinical Trial.

8

Tissue penetration of telavancin after intravenous administration in healthy subjects.

Sun HK, Duchin K, Nightingale CH, Shaw JP, Seroogy J, Nicolau DP. Sun HK, et al. Among authors: seroogy j. Antimicrob Agents Chemother. 2006 Feb;50(2):788-90. doi: 10.1128/AAC.50.2.788-790.2006. Antimicrob Agents Chemother. 2006. PMID: 16436747 Free PMC article.

9

Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: an in vitro study.

Patel JH, Churchwell MD, Seroogy JD, Barriere SL, Grio M, Mueller B. Patel JH, et al. Int J Artif Organs. 2009 Oct;32(10):745-51. doi: 10.1177/039139880903201006. Int J Artif Organs. 2009. PMID: 19943236

10

Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration.

Chang P, Perera V, Salinger DH, Merali S, Thanneer N, Back H, Seroogy JD, Gretler DD, Sehnert AJ, Palmisano M, Roy A. Chang P, et al. Among authors: seroogy jd. CPT Pharmacometrics Syst Pharmacol. 2024 Sep;13(9):1462-1475. doi: 10.1002/psp4.13197. Epub 2024 Aug 13. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 39136278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters